Second-Generation Antihistamine OTC Labeling Could Resemble Monograph
This article was originally published in The Tan Sheet
Executive Summary
OTC labeling for second-generation antihistamines - if the drugs were to switch - may not differ greatly from warnings on existing nonprescription allergic rhinitis symptom relief drugs.
You may also be interested in...
Zyrtec OTC Switch: Pfizer Says Rx Status Necessary For “Best Use” Of Drug
A forced OTC switch of Zyrtec would deprive consumers of the "health information component" doctors provide, which is needed for optimal care, Pfizer CEO Henry McKinnell said during the firm's April 24 annual meeting in Ann Arbor, Mich
Zyrtec OTC Switch: Pfizer Says Rx Status Necessary For “Best Use” Of Drug
A forced OTC switch of Zyrtec would deprive consumers of the "health information component" doctors provide, which is needed for optimal care, Pfizer CEO Henry McKinnell said during the firm's April 24 annual meeting in Ann Arbor, Mich
Zyrtec OTC Switch: Pfizer Says Rx Status Necessary For “Best Use” Of Drug
A forced OTC switch of Zyrtec would deprive consumers of the "health information component" doctors provide, which is needed for optimal care, Pfizer CEO Henry McKinnell said during the firm's April 24 annual meeting in Ann Arbor, Mich